This fellowship offers exposure to high-end breast and abdominal imaging via a variety of modalities and disease processes.
Candidates may consider two options:
(a) Combination Breast/Body Imaging (6 months each) OR
(b) 12 months comprehensive Breast Imaging.
Our department performs multimodality, state-of-the art clinical Abdominal Imaging examinations in CT, MRI, and Ultrasound. Research studies using PET-MRI are also performed.
Two 1.5 T Siemens MRI units and one 3T hybrid PET-MR unit are used for clinical and research imaging. There are two CT Scanners with dual energy capability, one used primarily for research.
A significant component of the fellowship will focus on oncologic imaging, predominantly CT and MRI. Fellows are exposed to complex cases, including GI malignancies (large volume colorectal carcinoma), gynecologic malignancies, and hepatic tumors. There is ample exposure to imaging and staging guidelines currently used by the National Comprehensive Cancer Network (NCCN). There is an emphasis on synoptic reporting for MRI of rectal carcinoma, HCC, and prostate carcinoma.
Fellows are expected to participate fully in weekly Multidisciplinary Case Conferences, where clinicians from various disciplines discuss complex oncology cases. This is an opportunity for fellows to gain experience presenting cases to an interdisciplinary audience, while at the same time learning the fine details that clinicians expect from radiology reports.
Fellows are given graded responsibility with respect to MR protocols, reporting, and case discussion.
As a number of referrals come from gastroenterologists, we also see a large volume of CT Colonography and Enterography cases, with excellent exposure to inflammatory bowel disorders. Approximately 350 CT Colonography cases are performed annually. We are also one of only 3 centres in Canada performing MR Elastography of the liver for fibrosis estimation.
The practice has a large genitourinary presence, receiving referrals for imaging of complex genetic disorders. There is also opportunity to become proficient in US-guided prostate biopsy.
Research: There is a large scope of research opportunities available. Ongoing projects include: (1) MR Elastography for fibrosis quantification in patients with chronic liver disease; (2) Hybrid imaging (PET-MRI) for prostate and rectal carcinoma; (3) Radiomics in pancreatic and prostate carcinoma. Several projects are done in collaboration with Lawson and Robarts research institutes in London.
The fellow will have one half day of protected academic time for proven research projects.
As a result of our large practice and state of the art technology, we are able to offer our fellows large exposure to all aspects of screening, diagnostic, interventional and research of breast Imaging.
Fellows have exposure to a high volume of digital screening mammograms, digital diagnostic mammograms, diagnostic ultrasounds, breast MRI and interventional procedures. Interventional procedures include: stereotactic core and vacuum assisted biopsies, ultrasound guided interventions, MRI guided vacuum assisted biopsy, preoperative wire and radioactive seed localizations and galactography.
We perform an average of 25,000 screening and diagnostic mammograms, 5000 breast ultrasounds, 1000 breast MRI, 800 ultrasound guided biopsies, 200 stereotaxic biopsies, 50 MRI guided biopsies and 300 wire localizations per year.
There are several Breast Imaging rounds occurring monthly with review of current cases, presentations of new techniques and advances in the field of Breast Imaging.
We offer on-site clinical research facilities with dedicated research scientists from Robarts and Lawson's Research Institute.
Ongoing research projects include: MRI of the breast, 3T PET MRI, photoacustic breast ultrasound and many other topics. Several projects are done in collaboration with Lawson and Robarts research institutes in London.
The fellow will have half day protected academic time for proven research projects.
For further information and details, please contact the Fellowship Coordinator, Kellie Griffin.